Changes to the website
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4695

Next 25
Website Changes
09/20/2018 Experimental drug `nothing short of miraculous` for father of 4 with super-rare brain tumor
09/17/2018 Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.
09/14/2018 Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition.
09/14/2018 Brain Tumor Webinar Series: Gamma Knife Radiosurgery Sunday, 9/16/18
09/13/2018 Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson
09/13/2018 Researchers make breakthrough in understanding aggressive brain cancer
09/10/2018 Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series
09/10/2018 NCI and Musella Foundation Award Grants for ONC201 Trials in Adult and Pediatric Brain Tumors
09/10/2018 Patient Foundation Collaboration to Advance ONC201 in DIPG and other H3 K27M-mutant Gliomas
09/06/2018 KKCO - Daybreak Anchor Sarah Schwabe`s Connection To Glioblastoma
09/06/2018 Optune Open House: St. Louis, MO
09/04/2018 Musella Foundation Copay Assistance Program is now open!
09/04/2018 Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group
09/01/2018 This brain cancer drug stock has been on a tear
08/29/2018 Optune open house Seattle, WA
08/27/2018 Aspirin affects tumor angiogenesis and sensitizes human glioblastoma endothelial cells to temozolomide, bevacizumab, and sunitinib impairing VEGF-related signaling.
08/24/2018 New glioblastoma clinical trial: mTOR inhibitor ABI-009
08/24/2018 Tocagen`s Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned First Interim Analysis
08/23/2018 Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.
08/23/2018 Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations
08/23/2018 CLINICAL TRIAL TO DISRUPT THE BLOOD-BRAIN BARRIER FOR BRAIN TUMOR TREATMENT LAUNCHED AT UNIVERSITY OF MARYLAND
08/22/2018 Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
08/16/2018 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
08/14/2018 The first human trials of this experimental, cancer-killing drug could change everything
08/01/2018 Tumor Treating Fields Utilization in a Glioblastoma Patient with a Preexisting Cardiac Pacemaker: The First Reported Case.



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740